An update on the mechanisms of the psychostimulant effects of caffeine

Journal of Neurochemistry

Volumn 105, Issue 4, 2008, Pages 1067-1079

  Ferré, Sergi ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Adenosine receptors; Caffeine; Dopamine receptors; Local modules; Psychostimulants; Receptor heteromers

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR; AMPA RECEPTOR; CAFFEINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GLUTAMIC ACID; PSYCHOSTIMULANT AGENT;

AROUSAL; BEHAVIOR; BINDING AFFINITY; BRAIN REGION; CORPUS STRIATUM; DENDRITIC SPINE; DOPAMINERGIC SYSTEM; HUMAN; LOCOMOTION; MACROGLIA; MOOD; MOTOR ACTIVITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNAPSE;

ADENOSINE; ANIMALS; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; RECEPTORS, PURINERGIC P1;

EID: 42549142092     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.05196.x     Document Type: Review

References (127)

1. Agnati L. F., Ferré S., Lluis C., Franco R. Fuxe K. (2003) Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol. Rev. 55, 509 550.
2. Antoniou K., Papadopoulou-Daifoti Z., Hyphantis T., Papathanasiou G., Bekris E., Marselos M., Panlilio L., Muller C. E., Goldberg S. R. Ferré S. (2005) A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors. Psychopharmacology 183, 154 162.
3. Ballarin M., Reiriz J., Ambrosio S. Mahy N. (1995) Effect of locally infused 2-chloroadenosine, an A1 receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum. Neurosci. Lett. 185, 29 32.
4. Basheer R., Strecker R. E., Thakkar M. M. McCarley R. W. (2004) Adenosine and sleep-wake regulation. Prog. Neurobiol. 73, 379 396.
5. Bedingfield J. B., King D. A. Holloway F. A. (1998) Cocaine and caffeine: conditioned place preference, locomotor activity, and additivity. Pharmacol. Biochem. Behav. 61, 291 296.
6. Bennett H. J. Semba K. (1998) Immunohistochemical localization of caffeine-induced c-Fos protein expression in the rat brain. J. Comp. Neurol. 401, 89 108.
7. Borycz J., Pereira M. F., Melani A., Rodrigues R. J., Kofalvi A., Panlilio L., Pedata F., Goldberg S. R., Cunha R. A. Ferré S. (2007) Differential glutamate-dependent and glutamate-independent adenosine A1 receptor-mediated modulation of dopamine release in different striatal compartments. J. Neurochem. 101, 355 363.
8. Brockwell N. T. Beninger R. J. (1996) The differential role of A1 and A2A adenosine receptor subtypes in locomotor activity and place conditioning in rats. Behav. Pharmacol. 7, 373 383.
9. Canals M., Marcellino D., Fanelli F. et al. (2003) Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J. Biol. Chem. 278, 46741 46749.
10. Carriba P., Ortiz O., Patkar K. et al. (2007) Striatal adenosine A(2A) and cannabinoid CB(1) receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology 32, 2249 2259.
11. Cauli O. Morelli M. (2005) Caffeine and the dopaminergic system. Behav. Pharmacol. 16, 63 77.
12. Cauli O., Pinna A., Valentini V. Morelli M. (2003) Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release. Neuropsychopharmacology 28, 1752 1759.
13. Ciruela F., Casado V., Rodrigues R. J. et al. (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J. Neurosci. 26, 2080 2087.
14. Conlay L. A., Conant J. A., deBros F. Wurtman R. (1997) Caffeine alters plasma adenosine levels. Nature 389, 136.
15. Corsi C., Melani A., Bianchi L. Pedata F. (2000) Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats. Neuroreport 11, 2591 2595.
16. De Luca M. A., Bassareo V., Bauer A. Di Chiara G. (2007) Caffeine and accumbens shell dopamine. J. Neurochem. 103, 157 163.
17. Durcan M. J. Morgan P. F. (1989) Evidence for adenosine A2 receptor involvement in the hypomobility effects of adenosine analogues in mice. Eur. J. Pharmacol. 168, 285 290.
18. El Yacoubi M., Ledent C., Menard J. F., Parmentier M., Costentin J. Vaugeois J. M. (2000) The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A (2A) receptors. Br. J. Pharmacol. 129, 1465 1473.
19. Elliott J. M. Beveridge T. J. (2005) Psychostimulants and monoamine transporters: upsetting the balance. Curr. Opin. Pharmacol. 5, 94 100.
20. Fedorchak P. M., Mesita J., Plater S. A. Brougham K. (2002) Caffeine-reinforced conditioned flavor preferences in rats. Behav. Neurosci. 116, 334 346.
21. Ferré S., von Euler G., Johansson B., Fredholm B. B. Fuxe K. (1991a) Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc. Natl Acad. Sci. USA 88, 7238 7241.
22. Ferré S., Herrera-Marschitz M., Grabowska-Anden M., Casas M., Ungerstedt U. Anden N. E. (1991b) Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice. Eur. J. Pharmacol. 192, 31 37.
23. Ferré S., Fuxe K., von Euler G., Johansson B. Fredholm B. B. (1992) Adenosine-dopamine interactions in the brain. Neuroscience 51, 501 512.
24. Ferré S., O'Connor W. T., Fuxe K. Ungerstedt U. (1993) The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J. Neurosci. 13, 5402 5406.
25. Ferré S., Popoli P., Gimenez-Llort L., Finnman U. B., Martinez E., Scotti de Carolis A. Fuxe K. (1994) Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors. Neuroreport 6, 73 76.
26. Ferré S., O'Connor W. T., Svenningsson P. et al. (1996) Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms. Eur. J. Neurosci. 8, 1545 1553.
27. Ferré S., Fredholm B. B., Morelli M., Popoli P. Fuxe K. (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20, 482 487.
28. Ferré S., Torvinen M., Antoniou K., Irenius E., Civelli O., Arenas E., Fredholm B. B. Fuxe K. (1998) Adenosine A1 receptor-mediated modulation of dopamine D1 receptors in stably cotransfected fibroblast cells. J. Biol. Chem. 273, 4718 4724.
29. Ferré S., Rimondini R., Popoli P., Reggio R., Pezzola A., Hansson A. C., Andersson A. Fuxe K. (1999) Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour. Eur. J. Neurosci. 11, 3884 3892.
30. Ferré S., Popoli P., Gimenez-Llort L., Rimondini R., Muller C. E., Stromberg I., Ogren S. O. Fuxe K. (2001) Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease. Parkinsonism Relat. Disord. 7, 235 241.
31. Ferré S., Karcz-Kubicha M., Hope B. T. et al. (2002) Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc. Natl Acad. Sci. USA 99, 11940 11945.
32. Ferré S., Borycz J., Goldberg S. R., Hope B. T., Morales M., Lluis C., Franco R., Ciruela F. Cunha R. (2005) Role of adenosine in the control of homosynaptic plasticity in striatal excitatory synapses. J. Integr. Neurosci. 4, 445 464.
33. Ferré S., Diamond I., Goldberg S. R., Yao L., Hourani S. M., Huang Z. L., Urade Y. Kitchen I. (2007a) Adenosine A (2A) receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain. Prog. Neurobiol. 83, 332 347.
34. Ferré S., Agnati L. F., Ciruela F., Lluis C., Woods A. S., Fuxe K. Franco R. (2007b) Neurotransmitter receptor heteromers and their integrative role in 'local modules': the striatal spine module. Brain Res. Rev. 55, 55 67.
35. Ferré S., Ciruela F., Woods A. S., Lluis C. Franco R. (2007c) Functional relevance of neurotransmitter receptor heteromers in the central nervous system. Trends Neurosci. 30, 440 446.
36. Fisone G., Borgkvist A. Usiello A. (2004) Caffeine as a psychomotor stimulant: mechanism of action. Cell. Mol. Life Sci. 61, 857 872.
37. Frary C. D., Johnson R. K. Wang M. Q. (2005) Food sources and intakes of caffeine in the diets of persons in the United States. J. Am. Diet. Assoc. 105, 110 113.
38. Fredholm B. B. (1980) Are methylxanthine effects due to antagonism of endogenous adenosine? Trends Pharmacol. Sci. 1, 129 132.
39. Fredholm B. B., Battig K., Holmen J., Nehlig A. Zvartau E. E. (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51, 83 133.
40. Fredholm B. B., Ijzerman A. P., Jacobson K. A., Klotz K. N. Linden J. (2001a) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527 552.
41. Fredholm B. B., Irenius E., Kull B. Schulte G. (2001b) Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem. Pharmacol. 61, 443 448.
42. Fuxe K. Ungerstedt U. (1974) Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists. Med. Biol. 52, 48 54.
43. Garrett B. E. Griffiths R. R. (1997) The role of dopamine in the behavioral effects of caffeine in animals and humans. Pharmacol. Biochem. Behav. 57, 533 541.
44. George S. R., O'Dowd B. F. Lee S. P. (2002) G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat. Rev. Drug Discov. 1, 808 820.
45. Gerfen C. R. (2004) Basal ganglia, in The Rat Nervous System (Paxinos G., ed pp. 445 508. Elsevier Academic Press, Amsterdam.
46. Ginés S., Hillion J., Torvinen M. et al. (2000) Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc. Natl Acad. Sci. USA 97, 8606 8611.
47. Golembiowska K. Zylewska A. (1997) Adenosine receptors - the role in modulation of dopamine and glutamate release in the rat striatum. Pol. J. Pharmacol. 49, 317 322.
48. Griffiths R. R. Woodson P. P. (1988) Reinforcing effects of caffeine in humans. J. Pharmacol. Exp. Ther. 246, 21 29.
49. Griffiths R. R., Juliano L. M. Chausmer A. (2003) Caffeine: pharmacology and clinical effects, in Principles of Addiction Medicine (Graham A. W., Schultz T. K., Mayo-Smth M. F., Ries R. K. Wilford B. B., eds Third Edition, pp. 193 224 American Society of Addiction Medicine, Chevy Chase, MD.
50. Gubitz A. K., Widdowson L., Kurokawa M., Kirkpatrick K. A. Richardson P. J. (1996) Dual signalling by the adenosine A2a receptor involves activation of both N- and P-type calcium channels by different G proteins and protein kinases in the same striatal nerve terminals. J. Neurochem. 67, 374 381.
51. Hakansson K., Galdi S., Hendrick J., Snyder G., Greengard P. Fisone G. (2006) Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors. J. Neurochem. 96, 482 488.
52. Halldner L., Lozza G., Lindstrom K. Fredholm B. B. (2000) Lack of tolerance to motor stimulant effects of a selective adenosine A (2A) receptor antagonist. Eur. J. Pharmacol. 406, 345 354.
53. Halldner L., Aden U., Dahlberg V., Johansson B., Ledent C. Fredholm B. B. (2004) The adenosine A1 receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion: a study in mice lacking adenosine A1 and/or A2A receptors. Neuropharmacology 46, 1008 10017.
54. Hanson G. R., Sandoval V., Riddle E. Fleckenstein A. E. (2004) Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implications. Ann. NY Acad. Sci. 1025, 146 150.
55. 2+ currents and excitability via a novel PLCβ1-IP3-calcineurin-signaling cascade. J. Neurosci. 20, 8987 8995.
56. Hertz L. Zielke R. (2004) Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci. 27, 735 743.
57. Hervé D., Le Moine C., Corvol J. C., Belluscio L., Ledent C., Fienberg A. A., Jaber M., Studler J. M. Girault J. A. (2001) Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. J. Neurosci. 21, 4390 4399.
58. Hillion J., Canals M., Torvinen M. et al. (2002) Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J. Biol. Chem. 277, 18091 18097.
59. Holtzman S. G., Mante S. Minneman K. P. (1991) Role of adenosine receptors in caffeine tolerance. J. Pharmacol. Exp. Ther. 256, 62 68.
60. Huang Z. L., Urade Y. Hayaishi O. (2007) Prostaglandins and adenosine in the regulation of sleep and wakefulness. Curr. Opin. Pharmacol. 7, 33 38.
61. Ikemoto S. (2007) Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res. Rev. 56, 27 78.
62. Jacobson K. A., Nikodijevic O., Padgett W. L., Gallo-Rodriguez C., Maillard M. Daly J. (1993) W. 8- (3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo. FEBS Lett. 323, 141 144.
63. Jacobson K. A., von Lubitz D. K., Daly J. W. Fredholm B. B. (1996) Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol. Sci. 17, 108 113.
64. James J. E. Rogers P. J. (2005) Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation. Psychopharmacology 182, 1 8.
65. 2+ channels, cytoplasmic messengers and proteins of the synaptic vesicle release complex. Trends Pharmacol. Sci. 22, 519 525.
66. Jiang H., Jackson-Lewis V., Muthane U., Dollison A., Ferreira M., Espinosa A., Parsons B. Przedborski S. (1993) Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats. Brain Res. 613, 347 351.
67. Juliano L. M. Griffiths R. R. (2004) A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology 176, 1 29.
68. Karcz-Kubicha M., Antoniou K., Terasmaa A. et al. (2003) Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacology 28, 1281 1291.
69. Kull B., Ferré S., Arslan G., Svenningsson P., Fuxe K., Owman C. Fredholm B. B. (1999) Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors. Biochem. Pharmacol. 58, 1035 1045.
70. Kuzmin A., Johansson B., Gimenez L., Ogren S. O. Fredholm B. B. (2006) Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation in mice. Eur. Neuropsychopharmacol. 16, 129 136.
71. Ledent C., Vaugeois J. M., Schiffmann S. N., Pedrazzini T., El Yacoubi M., Vanderhaeghen J. J., Costentin J., Heath J. K., Vassart G. Parmentier M. (1997) Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388, 674 678.
72. Lee K. W., Hong J. H., Choi I. Y. et al. (2002) Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase. J. Neurosci. 22, 7931 7940.
73. Lee K. W., Kim Y., Kim A. M., Helmin K., Nairn A. C. Greengard P. (2006) Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens. Proc. Natl Acad. Sci. USA 103, 3399 3404.
74. Leenders A. G. Sheng Z. H. (2005) Modulation of neurotransmitter release by the second messenger-activated protein kinases: implications for presynaptic plasticity. Pharmacol. Ther. 105, 69 84.
75. Lindskog M., Svenningsson P., Pozzi L., Kim Y., Fienberg A. A., Bibb J. A., Fredholm B. B., Nairn A. C., Greengard P. Fisone G. (2002) Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 418, 774 778.
76. Lupica C. R., Cass W. A., Zahniser N. R. Dunwiddie T. V. (1990) Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J. Pharmacol. Exp. Ther. 252, 1134 1141.
77. Marshall F. H. (2001) Heterodimerization of G-protein-coupled receptors in the CNS. Curr. Opin. Pharmacol. 1, 40 44.
78. Muller C. E. Ferré S. (2007) Blocking striatal adenosine A2A receptors: a new strategy for basal ganglia disorders. Recent Pat. CNS Drug Disc. 2, 1 21.
79. Mumford G. K. Holtzman S. G. (1991) Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat. J. Pharmacol. Exp. Ther. 258, 857 865.
80. Munzar P., Justinova Z., Kutkat S. W., Ferré S. Goldberg S. R. (2002) Adenosinergic modulation of the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology 161, 348 355.
81. Myers K. P. Izbicki E. V. (2006) Reinforcing and aversive effects of caffeine measured by flavor preference conditioning in caffeine-naive and caffeine-acclimated rats. Physiol. Behav. 88, 585 596.
82. Nehlig A. (1999) Are we dependent upon coffee and caffeine? A review on human and animal data Neurosci. Biobehav. Rev. 23, 563 576.
83. Nehlig A. Boyet S. (2000) Dose-response study of caffeine effects on cerebral functional activity with a specific focus on dependence. Brain Res. 858, 71 77.
84. Newman E. A. (2003) New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci. 26, 536 542.
85. Nishi A., Liu F., Matsuyama S., Hamada M., Higashi H., Nairn A. C. Greengard P. (2003) Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling. Proc. Natl Acad. Sci. USA 100, 1322 1327.
86. Okada M., Mizuno K. Kaneko S. (1996) Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci. Lett. 212, 53 56.
87. Okada M., Kiryu K., Kawata Y., Mizuno K., Wada K., Tasaki H. Kaneko S. (1997) Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis. Eur. J. Pharmacol. 321, 181 188.
88. Okada M., Nutt D. J., Murakami T., Zhu G., Kamata A., Kawata Y. Kaneko S. (2001) Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release. J. Neurosci. 21, 628 640.
89. Pascual O., Casper K. B., Kubera C., Zhang J., Revilla-Sanchez R., Sul J. Y., Takano H., Moss S. J., McCarthy K. Haydon P. G. (2005) Astrocytic purinergic signaling coordinates synaptic networks. Science 310, 113 116.
90. Patkina N. A. Zvartau E. E. (1998) Caffeine place conditioning in rats: comparison with cocaine and ethanol. Eur. Neuropsychopharmacol. 8, 287 291.
91. Pinna A., Fenu S. Morelli M. (2001) Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats. Synapse 39, 233 238.
92. Popoli P., Betto P., Reggio R. Ricciarello G. (1995) Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats. Eur. J. Pharmacol. 287, 215 217.
93. Popoli P., Gimenez-Llort L., Pezzola A., Reggio R., Martinez E., Fuxe K. Ferré S. (1996) Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents. Neurosci. Lett. 218, 209 213.
94. Popoli P., Reggio R., Pezzola A., Fuxe K. Ferré S. (1998) Adenosine A1 and A2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats. Neurosci. Lett. 251, 201 204.
95. Popoli P., Regio R. Pezzola A. (2000) Effects of SCH 58261, an adenosine A (2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake. Neuropsychopharmacology 22, 522 529.
96. Porkka-Heiskanen T., Strecker R. E. McCarley R. W. (2000) Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study. Neuroscience 99, 507 517.
97. Preston Z., Lee K., Widdowson L., Freeman T. C., Dixon A. K. Richardson P. J. (2000) Adenosine receptor expression and function in rat striatal cholinergic interneurons. Br. J. Pharmacol. 130, 886 890.
98. Prinster S. C., Hague C. Hall R. A. (2005) Heterodimerization of g protein-coupled receptors: specificity and functional significance. Pharmacol. Rev. 57, 289 298.
99. Pycock C. J. (1980) Turning behavior in animals. Neuroscience 5, 461 514.
100. 2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J. Neurochem. 88, 1151 1158.
101. Quarta D., Borycz J., Solinas M. et al. (2004b) Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation. J. Neurochem. 91, 873 880.
102. Rall T. W. (1982) Evolution of the mechanism of action of methylxanthines from calcium mobilizers to antagonists of adenosine receptors. Pharmacologist 24, 277 297.
103. Rashid A. J., So C. H., Kong M. M., Furtak T., El-Ghundi M., Cheng R., O'Dowd B. F. George S. R. (2007) D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc. Natl Acad. Sci. USA 104, 654 659.
104. Rosin D. L., Hettinger B. D., Lee A. Linden J. (2003) Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function. Neurology 61, S12 S18.
105. Schiffmann S. N., Fisone G., Moresco R., Cunha R. Ferré S. (2007) Adenosine A2A receptors and basal ganglia physiology. Prog. Neurobiol. 83, 277 292.
106. Shindou T., Nonaka H., Richardson P. J., Mori A., Kase H. Ichimura M. (2002) Presynaptic adenosine A2A receptors enhance GABAergic synaptic transmission via cyclic AMP dependent mechanisms in the rat globus pallidus. Br. J. Pharmacol. 136, 296 302.
107. Snyder S. H. (1985) Adenosine as a neuromodulator. Annu. Rev. Neurosci. 8, 103 124.
108. Snyder S. H. Ferris C. D. (2000) Novel neurotransmitters and their neuropsychiatric relevance. Am. J. Psychiatry 157, 1738 1751.
109. Snyder S. H., Katims J. J., Annau Z., Bruns R. F. Daly J. W. (1981) Adenosine receptors and behavioral actions of methylxanthines. Proc. Natl Acad. Sci. USA 78, 3260 3264.
110. Solinas M., Ferré S., You Z. B., Karcz-Kubicha M., Popoli P. Goldberg S. R. (2002) Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J. Neurosci. 22, 6321 6324.
111. Solinas M., Ferré S., Antoniou K. et al. (2005) Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats. Psychopharmacology 179, 576 586.
112. Solinas M., Panlilio L. V., Justinova Z., Yasar S. Goldberg S. R. (2006) Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats. Nat. Protoc. 1, 1194 1206.
113. Song I. Huganir R. L. (2002) Regulation of AMPA receptors during synaptic plasticity. Trends Neurosci. 25, 578 588.
114. Spealman R. D. (1988) Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism. Psychopharmacology 95, 19 24.
115. Spealman R. D. Coffin V. L. (1986) Behavioral effects of adenosine analogs in squirrel monkeys: relation to adenosine A2 receptors. Psychopharmacology 90, 419 421.
116. Stromberg I., Popoli P., Muller C. E., Ferré S. Fuxe K. (2000) Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum. Eur. J. Neurosci. 12, 4033 4037.
117. Sulzer D., Sonders M. S., Poulsen N. W. Galli A. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406 433.
118. Surmeier D. J., Song W. J. Yan Z. (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J. Neurosci. 16, 6579 6591.
119. Svenningsson P., Nomikos G. G., Ongini E. Fredholm B. B. (1977) Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience 79, 753 764.
120. Svenningsson P., Lindskog M., Ledent C., Parmentier M., Greengard P., Fredholm B. B. Fisone G. (2000) Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc. Natl Acad. Sci. USA 97, 1856 1860.
121. Tinley E. M., Durlach P. J. Yeomans M. R. (2004) How habitual caffeine consumption and dose influence flavour preference conditioning with caffeine. Physiol. Behav. 82, 317 324.
122. Torres G. E., Gainetdinov R. R. Caron M. G. (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 4, 13 25.
123. Ungerstedt U. (1971) Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. Suppl. 367, 69 93.
124. Valjent E., Pagès C., Hervé D., Girault J. A. Caboche J. (2004) Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur. J. Neurosci. 19, 1826 1836.
125. Wise R. A. (2004) Dopamine, learning and motivation. Nat. Neurosci. Rev. 5, 483 494.
126. Wood P. L., Kim H. S., Boyar W. C. Hutchison A. (1989) Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonists: A1 receptor mediation. Neuropharmacology 28, 21 25.
127. Zetterstrom T. Fillenz M. (1990) Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release. Eur. J. Pharmacol. 180, 137 143.